# Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

Study · id `cardio:ct-nct01514162` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01514162](<https://clinicaltrials.gov/study/NCT01514162>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01514162

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.

## Technical summary

Registry record NCT01514162. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2014-10 (actual). Results posted on 2017-05-31.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 245 participants (enrolled count; ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Primary completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Results first posted: 2017-05-31 (ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01514162, source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01514162-2019-02-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve
- Condition: Heart Valve Diseases
- Intervention (Device): Trifecta valve
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 89529f6d587e4749fa900b333a0f1920e4e5e32876e03c62ce3ec792ea2ac20b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
